 MIRAMAR, Fla., Aug. 13, 2021 GLOBE NEWSWIRE -- HCW Biologics Inc. the Company NASDAQ: HCWB, an innovative, biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended June 30, 2021. 